Focused on replicating its home market success in the eastern and western regions of the country.
As per IEA, India is estimated to add additional electricity demand equivalent to the current consumption of the United Kingdom over the next three years
The data is a nascent indicator of India’s long but steady journey towards becoming a wealthier nation with implications for varied consumption categories
The management’s revival strategy and strong macro make the stock worth carrying for long-term investors
Novelis generates 60 percent of EBITDA for Hindalco. It will not receive any proceeds from the sale of shares by its shareholders
The short term electricity trade business is less profitable than medium term and long term contracts
While EPAM expects revenue to decline in January-March, Capgemini projected a slower revenue growth in 2024 vis-a-vis 2023
The weak performance at Cenexi is constraining Gland Pharma’s earnings expectations
Sequential improvement in top line backed by improved demand visibility
Pharma companies are increasing focus on chronic medicines as this category of drugs continues to outperform the Indian market
Price hikes in the FSA segment are keenly awaited by the Street
The Drewry World Container index, which tracks spot container freight rates, is up 90 percent from the year-ago period
Max’s operating metrics are superior chiefly due to its hospitals being concentrated in the Delhi NCR region and focus on higher margin-yielding specialities
Utilisation levels in January 2024 surpassed 2023 highs indicating demand uptick
The proposed combined entity is likely to emerge as a pan-India fertiliser company.
The company will have to scale up its top line manifold to be able to protect its profitability
The company’s domestic business continues to grow at a faster pace than the India pharmaceutical market
The business is expected to normalise only from July-September (Q2 FY25) onwards
Rural recovery looks imminent on the back of higher government spending and lower inflation
Some much needed initiatives announced by the government for the agriculture sector
Sun Pharma’s specialty drugs business continue to grow at a brisk pace, helped by ramp-up of key products
An uptick in the RoA will be gradual as the bank continues to invest for the future
The research division proves to be a drag while manufacturing turns out to be the saviour
Scope for near-term RoA expansion looks limited though long-term story intact
The government managed to increase the capital outlay on defence services despite a rapid rise in defence pensions.